Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 40Carcinoma, Non-Small-Cell Lung 32Colorectal Neoplasms 27Ovarian Neoplasms 23Neoplasms 23Lung Neoplasms 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Pancreatic Neoplasms 17Leukemia, Myeloid, Acute 16Head and Neck Neoplasms 16Lymphoma, Non-Hodgkin 15Neoplasm Metastasis 14Fallopian Tube Neoplasms 14Glioblastoma 13Esophageal Neoplasms 12Rectal Neoplasms 11Lymphoma 11Squamous Cell Carcinoma of Head and Neck 10Central Nervous System Neoplasms 10Carcinoma, Ovarian Epithelial 10Recurrence 9Melanoma 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Leukemia 9Stomach Neoplasms 8Prostatic Neoplasms 8Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Liver Neoplasms 7

Interventions

napabucasin 3Irinotecan 3Gemcitabine 3Bevacizumab 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3entinostat 2Paclitaxel 2Leucovorin 2Fluorouracil 2sipuleucel-T 1pralsetinib 1pembrolizumab 1luprolide acetate gel depot 1lenvatinib 1interferon gamma-1b 1ficlatuzumab 1catumaxomab 1Vaccines 1Papillomavirus Vaccines 1Oncolytic Virotherapy 1Ocoxin 1Nivolumab 1Leuprolide 1Interferon-gamma 1Immunotherapy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Gefitinib 1Filgrastim 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms, Glandular and Epithelial × Drug Therapy × Clear all
NCT02759588 2023-01-05

GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer

Genelux Corporation

Phase 1/2 Completed
46 enrolled
Gynecologic

Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms, Poxviridae Infections, Vaccinia, Virus Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡